U.S. Capital Wealth Advisors LLC Lowers Holdings in Procter & Gamble Company (The) (NYSE:PG)

U.S. Capital Wealth Advisors LLC lowered its stake in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 41.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 49,325 shares of the company's stock after selling 34,274 shares during the quarter. U.S. Capital Wealth Advisors LLC's holdings in Procter & Gamble were worth $8,406,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of the stock. Cladis Investment Advisory LLC raised its position in Procter & Gamble by 5.2% in the fourth quarter. Cladis Investment Advisory LLC now owns 4,807 shares of the company's stock worth $806,000 after acquiring an additional 236 shares in the last quarter. FAS Wealth Partners Inc. grew its stake in shares of Procter & Gamble by 2.0% in the 4th quarter. FAS Wealth Partners Inc. now owns 27,690 shares of the company's stock valued at $4,642,000 after buying an additional 549 shares in the last quarter. Natural Investments LLC bought a new stake in shares of Procter & Gamble in the 4th quarter valued at approximately $2,121,000. Capital Investment Advisory Services LLC grew its stake in shares of Procter & Gamble by 13.8% in the 1st quarter. Capital Investment Advisory Services LLC now owns 37,709 shares of the company's stock valued at $6,426,000 after buying an additional 4,562 shares in the last quarter. Finally, World Investment Advisors boosted its position in Procter & Gamble by 6.0% during the first quarter. World Investment Advisors now owns 50,913 shares of the company's stock worth $8,677,000 after purchasing an additional 2,886 shares during the period. Institutional investors and hedge funds own 65.77% of the company's stock.

Procter & Gamble Price Performance

Shares of Procter & Gamble stock traded down $1.95 during trading on Tuesday, hitting $158.55. 3,038,285 shares of the stock traded hands, compared to its average volume of 7,476,599. The company has a quick ratio of 0.50, a current ratio of 0.71 and a debt-to-equity ratio of 0.47. The stock has a market cap of $371.73 billion, a price-to-earnings ratio of 25.16, a PEG ratio of 4.58 and a beta of 0.40. The firm's fifty day moving average is $162.07 and its 200-day moving average is $165.20. Procter & Gamble Company has a 52 week low of $156.58 and a 52 week high of $180.43.

Procter & Gamble (NYSE:PG - Get Free Report) last released its quarterly earnings data on Thursday, April 24th. The company reported $1.54 earnings per share for the quarter, topping the consensus estimate of $1.53 by $0.01. Procter & Gamble had a return on equity of 32.67% and a net margin of 18.46%. The business had revenue of $19.78 billion during the quarter, compared to analysts' expectations of $20.42 billion. During the same quarter last year, the business posted $1.52 EPS. The business's revenue was down 2.1% on a year-over-year basis. Research analysts expect that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Insider Buying and Selling

In other Procter & Gamble news, insider Moses Victor Javier Aguilar sold 10,520 shares of Procter & Gamble stock in a transaction on Monday, May 5th. The stock was sold at an average price of $158.67, for a total value of $1,669,208.40. Following the completion of the sale, the insider owned 25,182 shares of the company's stock, valued at approximately $3,995,627.94. This trade represents a 29.47% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Jennifer L. Davis sold 1,000 shares of Procter & Gamble stock in a transaction on Tuesday, April 29th. The stock was sold at an average price of $161.38, for a total value of $161,380.00. Following the completion of the sale, the chief executive officer directly owned 51,965 shares of the company's stock, valued at approximately $8,386,111.70. The trade was a 1.89% decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.18% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on the company. Bank of America reduced their price objective on Procter & Gamble from $190.00 to $180.00 and set a "buy" rating for the company in a research report on Friday, April 25th. Evercore ISI restated an "outperform" rating and issued a $190.00 target price (up from $170.00) on shares of Procter & Gamble in a research note on Tuesday, June 3rd. Piper Sandler lifted their price objective on Procter & Gamble from $160.00 to $164.00 and gave the stock a "neutral" rating in a research report on Monday, May 5th. Raymond James Financial reduced their target price on Procter & Gamble from $190.00 to $185.00 and set an "outperform" rating on the stock in a report on Friday, April 25th. Finally, JPMorgan Chase & Co. cut their price objective on Procter & Gamble from $181.00 to $172.00 and set an "overweight" rating on the stock in a report on Friday, April 11th. Eight equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have issued a strong buy rating to the company's stock. According to data from MarketBeat, Procter & Gamble has a consensus rating of "Moderate Buy" and an average target price of $178.45.

About Procter & Gamble

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.